A decadelong push to open a controversial infectious-disease research lab in Boston’s South End neighborhood is one giant step closer to fruition, with federal regulators signing off on the project.
In a notice published Wednesday in the Federal Register, the National Institutes of Health said that after “careful consideration” it has concluded that Boston University’s National Emerging Infectious Diseases Laboratories, which will work with some of the world’s deadliest germs, “poses minimal risk to the community surrounding the facility.”
Comments
This comment has been removed.
This comment has been removed.
Annie Dookhan could not be reached for comment.